Iterion Therapeutics Is A Clinical Stage Biopharmaceutical Company Based In Houstontexasdedicated To Developing Innovative Cancer Therapiesthe Company Focuses On The Wnt Beta Catenin Signaling Pathwaywhich Is Significant In Many Cancer Casesits Lead Candidatetegavivintis A First In Class Tbl1 Inhibitor That Promotes The Degradation Of Nuclear Beta Cateninaiming To Disrupt Oncogenic Pathways Effectively Tegavivint Has Shown Anti Tumor Activity In Preclinical Models Of Hepatocellular Carcinoma And Desmoid Tumorswith A Completed Phase 1 Trial Confirming Its Safety And Pharmacodynamic Activityiterion Is Also Advancing A Pipeline Of Second Generation Tbl1 Inhibitors To Broaden Its Therapeutic Applicationsthe Company Collaborates With Academic And Clinical Partners To Enhance The Development Of Its Therapiesparticularly For Patients With Wnt Beta Catenin Driven Cancers Who Have Limited Treatment Options
No conferences found for this company.
| Company Name | Iterion Therapeutics Inc |
| Country |
United States
|
| Address | 2450 Holcombe Blvd Ste J502 Houston Tx 77021 2039 United States |
| Telephone | Login to View |
| Login to View |
